Charles Massie
- Molecular Biology top 5%
- Cancer Research top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Nitzan RosenfeldFlorent MoulièreCarlos CaldasJames D. BrentonJavier García-CorbachoJonathan C. M. WanRichard D. BairdSimon Pacey
- Topics
- Prostate Cancer Treatment and Research (14 papers)Cancer Genomics and Diagnostics (8 papers)Epigenetics and DNA Methylation (7 papers)
- Partner nations
- United KingdomUnited StatesNorway
In The Last Decade
Charles Massie
39 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 2.2k
- Cancer Research 2.1k
- Pulmonary and Respiratory Medicine 1.3k
- Oncology 1.1k
- Pathology and Forensic Medicine 435
Countries citing papers authored by Charles Massie
This map shows the geographic impact of Charles Massie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Massie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Massie more than expected).
Fields of papers citing papers by Charles Massie
This network shows the impact of papers produced by Charles Massie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Massie. The network helps show where Charles Massie may publish in the future.
Co-authorship network of co-authors of Charles Massie
This figure shows the co-authorship network connecting the top 25 collaborators of Charles Massie. A scholar is included among the top collaborators of Charles Massie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Massie. Charles Massie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 68 | |
| 6 | 84 | |
| 7 | 8 | |
| 8 | Liquid biopsies come of age: towards implementation of circulating tumour DNAbreakdown → | 1766 |
| 9 | 10 | |
| 10 | 51 | |
| 11 | 30 | |
| 12 | 96 | |
| 13 | 284 | |
| 14 | 12 | |
| 15 | 216 | |
| 16 | 29 | |
| 17 | 180 | |
| 18 | 57 | |
| 19 | 99 | |
| 20 | 150 |
About Charles Massie
Charles Massie is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 42 papers that have together received 4.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Cancer Genomics and Diagnostics (8 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (1.3k citations) and Oncology (1.1k citations). Charles Massie has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include Nitzan Rosenfeld, Florent Moulière, Carlos Caldas, James D. Brenton, Javier García-Corbacho, Jonathan C. M. Wan, Richard D. Baird, Simon Pacey, Ian G. Mills and David E. Neal. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.